VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $5,971,000 | +192.1% | 30,063 | +110.4% | 0.13% | +104.7% |
Q4 2014 | $2,044,000 | -49.0% | 14,286 | -53.2% | 0.06% | -31.2% |
Q3 2014 | $4,007,000 | -75.1% | 30,544 | -76.0% | 0.09% | -76.0% |
Q2 2014 | $16,070,000 | +1515.1% | 127,422 | +1589.1% | 0.39% | +1835.0% |
Q1 2014 | $995,000 | +80.3% | 7,544 | +60.3% | 0.02% | +122.2% |
Q4 2013 | $552,000 | +8.4% | 4,706 | -3.6% | 0.01% | -18.2% |
Q3 2013 | $509,000 | – | 4,880 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |